- Autor
-
Pracoviště
1st Department of Neurology and Internationa... 1 Applied Neuroscience Research Group CEITEC M... 1 Atlantic Senior Fellow for Equity in Brain H... 1 Centro FONDAP de Gerociencia Salud Mental y ... 1 Centro de Biología Integrativa Facultad de C... 1 Departamento de Farmacologia Universidade Fe... 1 Department of Internal Medicine Kilimanjaro ... 1 Department of Neurology Juntendo University ... 1 Division of Molecular Biology and Human Gene... 1 Division of Neurology Department of Medicine... 1 Faculty of Medicine Mansoura University Daka... 1 Griffith Institute of Drug Discovery Griffit... 1 Institute of Global Health and Human Ecology... 1 Institute of Neurogenetics University of Lüb... 1 Instituto de Neurociencia Biomédica Facultad... 1 Neurodegenerative Disorders Collaborative La... 1 Neuroscience Research Australia; Faculty of ... 1 Norman Fixel Institute for Neurological Dise... 1 Pacific Parkinson's Research Centre Departme... 1 Research Institute of Disease of Old Age Gra... 1
- Publikační typ
- Kategorie
- Jazyk
- Země
- Časopis/zdroj
- Grantová podpora
- Nejvíce citované
Nejvíce citovaný článek - PubMed ID 31209787
Diffusion Kurtosis Imaging Detects Microstructural Changes in a Methamphetamine-Induced Mouse Model of Parkinson's Disease
-
Müller-Nedebock, Amica C
Autor Müller-Nedebock, Amica C Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa South African Medical Research Council/Stellenbosch University Genomics of Brain Disorders Research Unit, Stellenbosch University, Cape Town, South Africa
- Dekker, Marieke C J
- Farrer, Matthew J
-
Hattori, Nobutaka
Autor Hattori, Nobutaka ORCID Research Institute of Disease of Old Age, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan Department of Neurology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan Neurodegenerative Disorders Collaborative Laboratory, RIKEN Center for Brain Science, 2-1 Hirosawa, Wako, Saitama, 351-0106, Japan
- Lim, Shen-Yang
- Mellick, George D
- Rektorová, Irena
-
Salama, Mohamed
Autor Salama, Mohamed Institute of Global Health and Human Ecology (I-GHHE), The American University in Cairo (AUC), New Cairo, 11835, Egypt Faculty of Medicine, Mansoura University, Dakahleya, Egypt Atlantic Senior Fellow for Equity in Brain Health at the Global Brain Health Institute (GBHI), Trinity College Dublin (TCD), Dublin, Ireland
- Schuh, Artur F S
- Stoessl, A Jon
PubMed
37443150
PubMed Central
PMC10345014
DOI
10.1038/s41531-023-00535-8
PII: 10.1038/s41531-023-00535-8
Knihovny.cz E-zdroje
The biological basis of the neurodegenerative movement disorder, Parkinson's disease (PD), is still unclear despite it being 'discovered' over 200 years ago in Western Medicine. Based on current PD knowledge, there are widely varying theories as to its pathobiology. The aim of this article was to explore some of these different theories by summarizing the viewpoints of laboratory and clinician scientists in the PD field, on the biological basis of the disease. To achieve this aim, we posed this question to thirteen "PD experts" from six continents (for global representation) and collated their personal opinions into this article. The views were varied, ranging from toxin exposure as a PD trigger, to LRRK2 as a potential root cause, to toxic alpha-synuclein being the most important etiological contributor. Notably, there was also growing recognition that the definition of PD as a single disease should be reconsidered, perhaps each with its own unique pathobiology and treatment regimen.
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Upřesnit dle MeSH
Sdílet
Název dokumentu
Po ukončení testovacího provozu bude odkaz přesměrován adresu produkční verze portálu Medvik.